Fisker Inc./DE

$ Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000172099024000045 Filed on April 23, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$325.5M	$325.5M	$739.7M
YoY Change	-56.0%	-56.0%	-38.48%
Cash & Equivalents	$325.5M	$325.5M	$736.5M
Short-Term Investments	$0.00	$0.00	$3.140M
Other Short-Term Assets	$1.705M	$110.1M	$63.84M
YoY Change	-97.33%	72.49%	109.83%
Inventory	$406.5M	$406.5M	$4.276M
Prepaid Expenses
Receivables	$18.02M	$18.02M	$0.00
Other Receivables	$64.07M	$64.07M
Total Short-Term Assets	$924.2M	$924.2M	$831.5M
YoY Change	11.15%	11.15%	-32.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$570.9M	$658.2M	$387.1M
YoY Change	47.47%	56.51%	352.04%
Goodwill
YoY Change
Intangibles	$220.7M		$246.9M
YoY Change	-10.6%		6.65%
Long-Term Investments
YoY Change
Other Assets	$3.932M	$28.57M	$16.49M
YoY Change	-76.15%	73.29%	-33.07%
Total Long-Term Assets	$907.5M	$907.5M	$684.0M
YoY Change	32.69%	32.69%	89.94%
TOTAL ASSETS
Total Short-Term Assets	$924.2M	$924.2M	$831.5M
Total Long-Term Assets	$907.5M	$907.5M	$684.0M
Total Assets	$1.832B	$1.832B	$1.515B
YoY Change	20.87%	20.87%	-4.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$181.8M	$181.8M	$58.87M
YoY Change	208.88%	208.88%	109.19%
Accrued Expenses	$364.7M	$379.7M	$264.9M
YoY Change	37.66%	39.61%	232.68%
Deferred Revenue	$19.88M		$4.900M
YoY Change	305.76%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$291.7M	$291.7M
YoY Change
Total Short-Term Liabilities	$902.6M	$902.6M	$330.9M
YoY Change	172.8%	172.8%	194.56%
LONG-TERM LIABILITIES
Long-Term Debt	$935.2M	$935.2M	$660.8M
YoY Change	41.52%	41.52%	0.22%
Other Long-Term Liabilities	$516.0K	$91.91M	$43.22M
YoY Change	-98.81%	112.67%	103.55%
Total Long-Term Liabilities	$1.027B	$1.027B	$704.0M
YoY Change	45.89%	45.89%	3.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$902.6M	$902.6M	$330.9M
Total Long-Term Liabilities	$1.027B	$1.027B	$704.0M
Total Liabilities	$1.930B	$1.930B	$1.035B
YoY Change	86.47%	86.47%	30.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.107B		-$1.200B
YoY Change	75.56%		93.78%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$98.08M	-$98.08M	$480.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.832B	$1.832B	$1.515B
YoY Change	20.87%	20.87%	-4.87%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-6860000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-5947000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.80
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	343978989	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	303366068	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	292004136	shares
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001720990
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	Fisker Inc./DE
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.fiskerinc.com/20231231#RightOfUseAssetNet
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.fiskerinc.com/20231231#RightOfUseAssetNet
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.fiskerinc.com/20231231#RightOfUseAssetNet
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.fiskerinc.com/20231231#RightOfUseAssetNet
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39160
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3100340
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1888 Rosecrans Avenue
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Manhattan Beach
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90266
CY2023	dei	City Area Code CityAreaCode	833
CY2023	dei	Local Phone Number LocalPhoneNumber	434-7537
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, par value of $0.00001 per share
CY2022Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	19882000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15049000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7085000	usd
CY2023	dei	Trading Symbol TradingSymbol	FSRN
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1200000000	usd
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	325452000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	736549000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	70447000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18018000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	406505000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4276000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	103732000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87489000	usd
CY2023Q4	fsr	Equity Method Investments Current EquityMethodInvestmentsCurrent	0	usd
CY2022Q4	fsr	Equity Method Investments Current EquityMethodInvestmentsCurrent	3140000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	924154000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	831454000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	570907000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	387137000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	220743000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	246922000	usd
CY2023Q4	fsr	Right Of Use Asset Net RightOfUseAssetNet	87309000	usd
CY2022Q4	fsr	Right Of Use Asset Net RightOfUseAssetNet	33424000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	28574000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	16489000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	907533000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	683972000	usd
CY2023Q4	us-gaap	Assets Assets	1831687000	usd
CY2022Q4	us-gaap	Assets Assets	1515426000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	181839000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	58871000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	364691000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	260065000	usd
CY2023Q4	fsr	Contract With Customer Customer Advances And Deposits Current ContractWithCustomerCustomerAdvancesAndDepositsCurrent	29453000	usd
CY2022Q4	fsr	Contract With Customer Customer Advances And Deposits Current ContractWithCustomerCustomerAdvancesAndDepositsCurrent	4860000	usd
CY2023Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	291715000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	902629000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	330881000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	65723000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27884000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	516000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15334000	usd
CY2023Q4	fsr	Convertible Senior Notes Noncurrent ConvertibleSeniorNotesNoncurrent	935228000	usd
CY2022Q4	fsr	Convertible Senior Notes Noncurrent ConvertibleSeniorNotesNoncurrent	660822000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	25673000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1027140000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	704040000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1929769000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1034921000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2008602000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1650196000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2106688000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1166741000	usd
CY2023Q4	fsr	Receivable For At The Market Offering ReceivableForAtTheMarketOffering	0	usd
CY2022Q4	fsr	Receivable For At The Market Offering ReceivableForAtTheMarketOffering	2953000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-98082000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	480505000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1831687000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1515426000	usd
CY2023	us-gaap	Revenues Revenues	272883000	usd
CY2022	us-gaap	Revenues Revenues	342000	usd
CY2021	us-gaap	Revenues Revenues	106000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	558821000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	263000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	88000	usd
CY2023	us-gaap	Gross Profit GrossProfit	-285938000	usd
CY2022	us-gaap	Gross Profit GrossProfit	79000	usd
CY2021	us-gaap	Gross Profit GrossProfit	18000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	249160000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	106417000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42398000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67357000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	423907000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	286856000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	316517000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	530324000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	329254000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-602455000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-530245000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-329236000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7190000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-119000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-402000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	24745000	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	10378000	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	627000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	18745000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	18426000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	6546000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-138436000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5389000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2039000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2667000	usd
CY2023	fsr	Unrealized Loss Gain Recognized On Equity Securities UnrealizedLossGainRecognizedOnEquitySecurities	-1791000	usd
CY2022	fsr	Unrealized Loss Gain Recognized On Equity Securities UnrealizedLossGainRecognizedOnEquitySecurities	-6860000	usd
CY2021	fsr	Unrealized Loss Gain Recognized On Equity Securities UnrealizedLossGainRecognizedOnEquitySecurities	0	usd
CY2023	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-327823000	usd
CY2022	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
CY2021	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-336193000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17066000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-142090000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-938648000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-547311000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-471326000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1299000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	185000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-939947000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-547496000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-471341000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.73
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.73
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.80
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	343978989	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	303366068	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	292004136	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	907130000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5622000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	403000	usd
CY2021	fsr	Receivable For Warrants Exercised ReceivableForWarrantsExercised	459000	usd
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	365080000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	0	usd
CY2021	fsr	Adjustments To Additional Paid In Capital Purchase Of Capped Call Options AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallOptions	96788000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	89477000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-471341000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	800042000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19602000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	592000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	20778000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	186987000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-547496000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	480505000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8176000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	89000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	6000000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	133657000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	213438000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-939947000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-98082000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-939947000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-547496000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-471341000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	8176000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	19602000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5622000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1734000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1474000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	373000	usd
CY2023	fsr	Allowance For Note Receivable AllowanceForNoteReceivable	8357000	usd
CY2022	fsr	Allowance For Note Receivable AllowanceForNoteReceivable	0	usd
CY2021	fsr	Allowance For Note Receivable AllowanceForNoteReceivable	0	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	88878000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	7285000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	699000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	10235000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4463000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2576000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	233929000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023	fsr	Change In Fair Value Of Liabilities ChangeInFairValueOfLiabilities	327823000	usd
CY2022	fsr	Change In Fair Value Of Liabilities ChangeInFairValueOfLiabilities	0	usd
CY2021	fsr	Change In Fair Value Of Liabilities ChangeInFairValueOfLiabilities	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	138436000	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1791000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-3975000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	1469000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	636156000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17528000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	45555000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	33442000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	53194000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	43797000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	205471000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	99578000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	66253000	usd
CY2023	fsr	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	26677000	usd
CY2022	fsr	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	9034000	usd
CY2021	fsr	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	2773000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6431000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4118000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1395000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-668931000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-452537000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-301270000	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	10000000	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	8357000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	227587000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	190989000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	134386000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-235944000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-200989000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-134386000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	450000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	667500000	usd
CY2023	fsr	Proceeds From Payments For Debt Issuance Costs ProceedsFromPaymentsForDebtIssuanceCosts	25000	usd
CY2022	fsr	Proceeds From Payments For Debt Issuance Costs ProceedsFromPaymentsForDebtIssuanceCosts	0	usd
CY2021	fsr	Proceeds From Payments For Debt Issuance Costs ProceedsFromPaymentsForDebtIssuanceCosts	-209000	usd
CY2023	fsr	Payments For Capped Call Option PaymentsForCappedCallOption	0	usd
CY2022	fsr	Payments For Capped Call Option PaymentsForCappedCallOption	0	usd
CY2021	fsr	Payments For Capped Call Option PaymentsForCappedCallOption	96788000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	8314000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	89023000	usd
CY2023	fsr	Payments For Redemption Of Unexercised Warrants PaymentsForRedemptionOfUnexercisedWarrants	0	usd
CY2022	fsr	Payments For Redemption Of Unexercised Warrants PaymentsForRedemptionOfUnexercisedWarrants	0	usd
CY2021	fsr	Payments For Redemption Of Unexercised Warrants PaymentsForRedemptionOfUnexercisedWarrants	22000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	18303000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2023	fsr	Payments To Tax Authorities For Statutory Tax Withholdings PaymentsToTaxAuthoritiesForStatutoryTaxWithholdings	63000	usd
CY2022	fsr	Payments To Tax Authorities For Statutory Tax Withholdings PaymentsToTaxAuthoritiesForStatutoryTaxWithholdings	1562000	usd
CY2021	fsr	Payments To Tax Authorities For Statutory Tax Withholdings PaymentsToTaxAuthoritiesForStatutoryTaxWithholdings	9869000	usd
CY2023	fsr	Proceeds From Repayments For Stock Options Exercised ProceedsFromRepaymentsForStockOptionsExercised	-26000	usd
CY2022	fsr	Proceeds From Repayments For Stock Options Exercised ProceedsFromRepaymentsForStockOptionsExercised	2154000	usd
CY2021	fsr	Proceeds From Repayments For Stock Options Exercised ProceedsFromRepaymentsForStockOptionsExercised	5616000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	135928000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	190492000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1867000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3448000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	565694000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	187636000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	646937000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1469000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-340650000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-465890000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	211281000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736549000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1202439000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	991158000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395899000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736549000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1202439000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	736549000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1202439000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	991158000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736549000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1202439000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	991158000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	325452000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	736549000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1202439000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	70447000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395899000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736549000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1202439000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-340650000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-465890000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	211281000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	16688000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	17985000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	338000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	46000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-top:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP required management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities in the consolidated financial statements and accompanying notes. Significant estimates, assumptions and judgments made by management include, inventory valuation, warranty reserve and calculating the standalone selling price for revenue recognition, fair value of convertible notes payable and other items requiring judgment. Estimates are based on assumptions that we believe are reasonable under the circumstances. Due to the inherent uncertainty involved with estimates, actual results may differ. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future period</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">s.</span></div>
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	70400000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk and Off-balance Sheet Risk </span></div>Cash and cash equivalents are financial instruments that are potentially subject to concentrations of credit risk. The Company’s cash and cash equivalents are deposited in accounts at large financial institutions, and amounts may exceed federally insured limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash and cash equivalents are held. The Company has no financial instruments with off-balance sheet risk of loss.
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2023	fsr	Contract With Customer Additions ContractWithCustomerAdditions	46577000	usd
CY2023	fsr	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	-1022000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45555000	usd
CY2023Q4	fsr	Revenue Remaining Performance Obligation Amount1 RevenueRemainingPerformanceObligationAmount1	19900000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023	fsr	Warranty Period WarrantyPeriod	P6Y
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	fsr	Provision For Excess Or Obsolete Inventory ProvisionForExcessOrObsoleteInventory	1200000	usd
CY2023	fsr	Inventory Net Realizable Value InventoryNetRealizableValue	232700000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Advertising Expense AdvertisingExpense	28000000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	9300000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	6300000	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1800000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-6900000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	138400000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	194271000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	564386000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	604185000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	327823000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	564386000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	183754000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	698000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2825000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	219926000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3578000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	406505000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4276000	usd
CY2023	fsr	Inventory Excess And Obsolescence Reserve InventoryExcessAndObsolescenceReserve	1200000	usd
CY2023	fsr	Inventory Net Realizable Value InventoryNetRealizableValue	232700000	usd
CY2023Q4	fsr	Prepaid Advanced Payments To Suppliers PrepaidAdvancedPaymentsToSuppliers	34845000	usd
CY2022Q4	fsr	Prepaid Advanced Payments To Suppliers PrepaidAdvancedPaymentsToSuppliers	46107000	usd
CY2023Q4	fsr	Prepaid Value Added Tax Receivable PrepaidValueAddedTaxReceivable	64066000	usd
CY2022Q4	fsr	Prepaid Value Added Tax Receivable PrepaidValueAddedTaxReceivable	27928000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2784000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2951000	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	332000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	4999000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1705000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5504000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	103732000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87489000	usd
CY2022	fsr	Non Cash Operating Lease Right Of Use Asset NonCashOperatingLeaseRightOfUseAsset	33400000	usd
CY2023	fsr	Non Cash Operating Lease Liabilities NonCashOperatingLeaseLiabilities	80800000	usd
CY2022	fsr	Non Cash Operating Lease Liabilities NonCashOperatingLeaseLiabilities	35000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	32304000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	59223000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	220743000	usd
CY2023	fsr	Non Cash Operating Lease Right Of Use Asset NonCashOperatingLeaseRightOfUseAsset	87300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	630087000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	389618000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	59180000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2481000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	570907000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	387137000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	56700000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1900000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	800000	usd
CY2023	us-gaap	Depreciation Depreciation	43800000	usd
CY2022	us-gaap	Depreciation Depreciation	0	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	500000	usd
CY2022	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	33000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	258304000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	37561000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	220743000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	252304000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5257000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	247047000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32300000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	32304000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	32304000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	32304000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	32304000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	87309000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33424000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15049000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7085000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	65723000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27884000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	16421000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	5690000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	2279000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	962000	usd
CY2023	us-gaap	Lease Cost LeaseCost	18700000	usd
CY2022	us-gaap	Lease Cost LeaseCost	6652000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y7M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0960
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0566
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	15088000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4348000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	65151000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	19076000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22147000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	21355000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	20440000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	12064000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9516000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	17789000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	103311000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22539000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	80772000	usd
CY2023	fsr	Finance Lease Right Of Use Asset At Lease Inception FinanceLeaseRightOfUseAssetAtLeaseInception	21200000	usd
CY2022	fsr	Finance Lease Right Of Use Asset At Lease Inception FinanceLeaseRightOfUseAssetAtLeaseInception	4300000	usd
CY2023Q4	fsr	Remaining Finance Lease Liability RemainingFinanceLeaseLiability	2900000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1700000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	100000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	19400000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4500000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5267000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	3079000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	19375000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4481000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3932000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8929000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	28574000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	16489000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	364691000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	260065000	usd
CY2023Q4	fsr	Reservations From Customers Noncurrent ReservationsFromCustomersNoncurrent	0	usd
CY2022Q4	fsr	Reservations From Customers Noncurrent ReservationsFromCustomersNoncurrent	15334000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	516000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	516000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15334000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	312833000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	51667000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	667500000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1032000000	usd
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	fsr	Number Of Milestone Performance Conditions NumberOfMilestonePerformanceConditions	3	milestone
CY2023Q4	fsr	Class Of Warrant Or Right Number Of Warrants That Vest Upon Milestone Achievement Shares ClassOfWarrantOrRightNumberOfWarrantsThatVestUponMilestoneAchievementShares	19474454	shares
CY2023Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	174297000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	174297000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-939947000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-547496000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-471341000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	343978989	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	303366068	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	292004136	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.73
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.73
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.80
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.80
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	396052943	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	71046895	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	64557391	shares
CY2023	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8176000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19602000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5622000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	15882711	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17695560	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.44
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M6D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	495700	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.15
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	213048	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.13
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	297616	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	12.09
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17680596	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.51
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.05
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	60340	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.44
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	387041	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.87
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17240215	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.29
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M18D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.745
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.752
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.749
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.764
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.034
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.040
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.037
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.043
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.06
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	24.48
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	17240215	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.29
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P3Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25800000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25800000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1800000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	26300000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.05
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.25
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.96
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	22200000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-943801000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-549514000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-470603000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5153000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2203000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-723000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-938648000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-547311000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-471326000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1271000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	221000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	15000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1271000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	221000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	28000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-36000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	28000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-36000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1299000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	185000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.009
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.008
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.145
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.253
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.200
CY2023	fsr	Effective Income Tax Rate Reconciliation Fair Value Of Derivatives EffectiveIncomeTaxRateReconciliationFairValueOfDerivatives	-0.073
CY2022	fsr	Effective Income Tax Rate Reconciliation Fair Value Of Derivatives EffectiveIncomeTaxRateReconciliationFairValueOfDerivatives	0.000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021	fsr	Effective Income Tax Rate Reconciliation Fair Value Of Derivatives EffectiveIncomeTaxRateReconciliationFairValueOfDerivatives	-0.062
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.009
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2023	fsr	Deferred Tax Assets Operating Loss Carryforwards Expiration Period DeferredTaxAssetsOperatingLossCarryforwardsExpirationPeriod	P5Y
CY2023	fsr	Percentage Of Taxable Income Limitation PercentageOfTaxableIncomeLimitation	0.80
CY2023	fsr	Deferred Tax Assets Operating Loss Carryforwards Expiration Year DeferredTaxAssetsOperatingLossCarryforwardsExpirationYear	2036
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	255442000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	147789000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	507000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	11461000	usd
CY2023Q4	fsr	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	14033000	usd
CY2022Q4	fsr	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	6793000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	111985000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	82084000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	18274000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7042000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	400241000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	255169000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	16196000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	6902000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	16196000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6902000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	384037000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	248230000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	37000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	135800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	248230000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	108794000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14562000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	135807000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	139436000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	94232000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	384037000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	248230000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	108794000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	962000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	798000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2975000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	968000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	229000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2007000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	871000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2875000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	129000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2975000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	968000	usd
CY2023	fsr	Number Of Foreign Jurisdictions NumberOfForeignJurisdictions	3	jurisdiction
CY2023Q4	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	0	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001720990-24-000045-index-headers.html	Edgar Link	pending
0001720990-24-000045-index.html	Edgar Link	pending
0001720990-24-000045.txt	Edgar Link	pending
0001720990-24-000045-xbrl.zip	Edgar Link	pending
exhibit1020securitiespur.htm	Edgar Link	pending
exhibit1020securitiespur001.jpg	Edgar Link	pending
exhibit1020securitiespur002.jpg	Edgar Link	pending
exhibit1020securitiespur003.jpg	Edgar Link	pending
exhibit1020securitiespur004.jpg	Edgar Link	pending
exhibit1020securitiespur005.jpg	Edgar Link	pending
exhibit1020securitiespur006.jpg	Edgar Link	pending
exhibit1020securitiespur007.jpg	Edgar Link	pending
exhibit1020securitiespur008.jpg	Edgar Link	pending
exhibit1020securitiespur009.jpg	Edgar Link	pending
exhibit1020securitiespur010.jpg	Edgar Link	pending
exhibit1020securitiespur011.jpg	Edgar Link	pending
exhibit1020securitiespur012.jpg	Edgar Link	pending
exhibit1020securitiespur013.jpg	Edgar Link	pending
exhibit1020securitiespur014.jpg	Edgar Link	pending
exhibit1020securitiespur015.jpg	Edgar Link	pending
exhibit1020securitiespur016.jpg	Edgar Link	pending
exhibit1020securitiespur017.jpg	Edgar Link	pending
exhibit1020securitiespur018.jpg	Edgar Link	pending
exhibit1020securitiespur019.jpg	Edgar Link	pending
exhibit1020securitiespur020.jpg	Edgar Link	pending
exhibit1020securitiespur021.jpg	Edgar Link	pending
exhibit1020securitiespur022.jpg	Edgar Link	pending
exhibit1020securitiespur023.jpg	Edgar Link	pending
exhibit1020securitiespur024.jpg	Edgar Link	pending
exhibit1020securitiespur025.jpg	Edgar Link	pending
exhibit1020securitiespur026.jpg	Edgar Link	pending
exhibit1020securitiespur027.jpg	Edgar Link	pending
exhibit1020securitiespur028.jpg	Edgar Link	pending
exhibit1020securitiespur029.jpg	Edgar Link	pending
exhibit1020securitiespur030.jpg	Edgar Link	pending
exhibit1020securitiespur031.jpg	Edgar Link	pending
exhibit1020securitiespur032.jpg	Edgar Link	pending
exhibit1020securitiespur033.jpg	Edgar Link	pending
exhibit1020securitiespur034.jpg	Edgar Link	pending
exhibit1020securitiespur035.jpg	Edgar Link	pending
exhibit1020securitiespur036.jpg	Edgar Link	pending
exhibit1020securitiespur037.jpg	Edgar Link	pending
exhibit1020securitiespur038.jpg	Edgar Link	pending
exhibit1020securitiespur039.jpg	Edgar Link	pending
exhibit1020securitiespur040.jpg	Edgar Link	pending
exhibit1020securitiespur041.jpg	Edgar Link	pending
exhibit1020securitiespur042.jpg	Edgar Link	pending
exhibit1020securitiespur043.jpg	Edgar Link	pending
exhibit1020securitiespur044.jpg	Edgar Link	pending
exhibit1020securitiespur045.jpg	Edgar Link	pending
exhibit1020securitiespur046.jpg	Edgar Link	pending
exhibit1020securitiespur047.jpg	Edgar Link	pending
exhibit1020securitiespur048.jpg	Edgar Link	pending
exhibit1020securitiespur049.jpg	Edgar Link	pending
exhibit1020securitiespur050.jpg	Edgar Link	pending
exhibit1020securitiespur051.jpg	Edgar Link	pending
exhibit1020securitiespur052.jpg	Edgar Link	pending
exhibit1020securitiespur053.jpg	Edgar Link	pending
exhibit1020securitiespur054.jpg	Edgar Link	pending
exhibit1020securitiespur055.jpg	Edgar Link	pending
exhibit1020securitiespur056.jpg	Edgar Link	pending
exhibit1020securitiespur057.jpg	Edgar Link	pending
exhibit1020securitiespur058.jpg	Edgar Link	pending
exhibit1020securitiespur059.jpg	Edgar Link	pending
exhibit1020securitiespur060.jpg	Edgar Link	pending
exhibit1020securitiespur061.jpg	Edgar Link	pending
exhibit1020securitiespur062.jpg	Edgar Link	pending
exhibit1020securitiespur063.jpg	Edgar Link	pending
exhibit1021amendmentno1t.htm	Edgar Link	pending
exhibit1021amendmentno1t001.jpg	Edgar Link	pending
exhibit1021amendmentno1t002.jpg	Edgar Link	pending
exhibit1021amendmentno1t003.jpg	Edgar Link	pending
exhibit1021amendmentno1t004.jpg	Edgar Link	pending
exhibit1021amendmentno1t005.jpg	Edgar Link	pending
exhibit1021amendmentno1t006.jpg	Edgar Link	pending
exhibit1022-amendmentand.htm	Edgar Link	pending
exhibit1022-amendmentand001.jpg	Edgar Link	pending
exhibit1022-amendmentand002.jpg	Edgar Link	pending
exhibit1022-amendmentand003.jpg	Edgar Link	pending
exhibit1022-amendmentand004.jpg	Edgar Link	pending
exhibit1022-amendmentand005.jpg	Edgar Link	pending
exhibit1023-guaranty.htm	Edgar Link	pending
exhibit1023-guaranty001.jpg	Edgar Link	pending
exhibit1023-guaranty002.jpg	Edgar Link	pending
exhibit1023-guaranty003.jpg	Edgar Link	pending
exhibit1023-guaranty004.jpg	Edgar Link	pending
exhibit1023-guaranty005.jpg	Edgar Link	pending
exhibit1023-guaranty006.jpg	Edgar Link	pending
exhibit1023-guaranty007.jpg	Edgar Link	pending
exhibit1023-guaranty008.jpg	Edgar Link	pending
exhibit1023-guaranty009.jpg	Edgar Link	pending
exhibit1023-guaranty010.jpg	Edgar Link	pending
exhibit1023-guaranty011.jpg	Edgar Link	pending
exhibit1023-guaranty012.jpg	Edgar Link	pending
exhibit1023-guaranty013.jpg	Edgar Link	pending
exhibit1023-guaranty014.jpg	Edgar Link	pending
exhibit1023-guaranty015.jpg	Edgar Link	pending
exhibit1023-guaranty016.jpg	Edgar Link	pending
exhibit1023-guaranty017.jpg	Edgar Link	pending
exhibit1024amendedandres.htm	Edgar Link	pending
exhibit1024amendedandres001.jpg	Edgar Link	pending
exhibit1024amendedandres002.jpg	Edgar Link	pending
exhibit1024amendedandres003.jpg	Edgar Link	pending
exhibit1024amendedandres004.jpg	Edgar Link	pending
exhibit1024amendedandres005.jpg	Edgar Link	pending
exhibit1024amendedandres006.jpg	Edgar Link	pending
exhibit1024amendedandres007.jpg	Edgar Link	pending
exhibit1024amendedandres008.jpg	Edgar Link	pending
exhibit1024amendedandres009.jpg	Edgar Link	pending
exhibit1024amendedandres010.jpg	Edgar Link	pending
exhibit1024amendedandres011.jpg	Edgar Link	pending
exhibit1024amendedandres012.jpg	Edgar Link	pending
exhibit1024amendedandres013.jpg	Edgar Link	pending
exhibit1024amendedandres014.jpg	Edgar Link	pending
exhibit1024amendedandres015.jpg	Edgar Link	pending
exhibit1024amendedandres016.jpg	Edgar Link	pending
exhibit1024amendedandres017.jpg	Edgar Link	pending
exhibit1024amendedandres018.jpg	Edgar Link	pending
exhibit1024amendedandres019.jpg	Edgar Link	pending
exhibit1024amendedandres020.jpg	Edgar Link	pending
exhibit1024amendedandres021.jpg	Edgar Link	pending
exhibit1024amendedandres022.jpg	Edgar Link	pending
exhibit1024amendedandres023.jpg	Edgar Link	pending
exhibit1024amendedandres024.jpg	Edgar Link	pending
exhibit1024amendedandres025.jpg	Edgar Link	pending
exhibit1024amendedandres026.jpg	Edgar Link	pending
exhibit1024amendedandres027.jpg	Edgar Link	pending
exhibit1024amendedandres028.jpg	Edgar Link	pending
exhibit1024amendedandres029.jpg	Edgar Link	pending
exhibit1024amendedandres030.jpg	Edgar Link	pending
exhibit1024amendedandres031.jpg	Edgar Link	pending
exhibit1024amendedandres032.jpg	Edgar Link	pending
exhibit1024amendedandres033.jpg	Edgar Link	pending
exhibit1024amendedandres034.jpg	Edgar Link	pending
exhibit1024amendedandres035.jpg	Edgar Link	pending
exhibit1024amendedandres036.jpg	Edgar Link	pending
exhibit1024amendedandres037.jpg	Edgar Link	pending
exhibit1024amendedandres038.jpg	Edgar Link	pending
exhibit1024amendedandres039.jpg	Edgar Link	pending
exhibit1024amendedandres040.jpg	Edgar Link	pending
exhibit1024amendedandres041.jpg	Edgar Link	pending
exhibit1024amendedandres042.jpg	Edgar Link	pending
exhibit1024amendedandres043.jpg	Edgar Link	pending
exhibit1024amendedandres044.jpg	Edgar Link	pending
exhibit1024amendedandres045.jpg	Edgar Link	pending
exhibit1024amendedandres046.jpg	Edgar Link	pending
exhibit1024amendedandres047.jpg	Edgar Link	pending
exhibit1024amendedandres048.jpg	Edgar Link	pending
exhibit1024amendedandres049.jpg	Edgar Link	pending
exhibit1024amendedandres050.jpg	Edgar Link	pending
exhibit1025secondamendme.htm	Edgar Link	pending
exhibit1025secondamendme001.jpg	Edgar Link	pending
exhibit1025secondamendme002.jpg	Edgar Link	pending
exhibit1025secondamendme003.jpg	Edgar Link	pending
exhibit1025secondamendme004.jpg	Edgar Link	pending
exhibit1025secondamendme005.jpg	Edgar Link	pending
exhibit1025secondamendme006.jpg	Edgar Link	pending
exhibit1025secondamendme007.jpg	Edgar Link	pending
exhibit1025secondamendme008.jpg	Edgar Link	pending
exhibit1025secondamendme009.jpg	Edgar Link	pending
exhibit410secondsuppleme.htm	Edgar Link	pending
exhibit410secondsuppleme001.jpg	Edgar Link	pending
exhibit410secondsuppleme002.jpg	Edgar Link	pending
exhibit410secondsuppleme003.jpg	Edgar Link	pending
exhibit410secondsuppleme004.jpg	Edgar Link	pending
exhibit410secondsuppleme005.jpg	Edgar Link	pending
exhibit410secondsuppleme006.jpg	Edgar Link	pending
exhibit410secondsuppleme007.jpg	Edgar Link	pending
exhibit410secondsuppleme008.jpg	Edgar Link	pending
exhibit410secondsuppleme009.jpg	Edgar Link	pending
exhibit410secondsuppleme010.jpg	Edgar Link	pending
exhibit410secondsuppleme011.jpg	Edgar Link	pending
exhibit410secondsuppleme012.jpg	Edgar Link	pending
exhibit410secondsuppleme013.jpg	Edgar Link	pending
exhibit410secondsuppleme014.jpg	Edgar Link	pending
exhibit411-thirdsuppleme.htm	Edgar Link	pending
exhibit411-thirdsuppleme001.jpg	Edgar Link	pending
exhibit411-thirdsuppleme002.jpg	Edgar Link	pending
exhibit411-thirdsuppleme003.jpg	Edgar Link	pending
exhibit411-thirdsuppleme004.jpg	Edgar Link	pending
exhibit411-thirdsuppleme005.jpg	Edgar Link	pending
exhibit411-thirdsuppleme006.jpg	Edgar Link	pending
exhibit411-thirdsuppleme007.jpg	Edgar Link	pending
exhibit411-thirdsuppleme008.jpg	Edgar Link	pending
exhibit411-thirdsuppleme009.jpg	Edgar Link	pending
exhibit411-thirdsuppleme010.jpg	Edgar Link	pending
exhibit411-thirdsuppleme011.jpg	Edgar Link	pending
exhibit411-thirdsuppleme012.jpg	Edgar Link	pending
exhibit411-thirdsuppleme013.jpg	Edgar Link	pending
exhibit46seriesa-1senior.htm	Edgar Link	pending
exhibit46seriesa-1senior001.jpg	Edgar Link	pending
exhibit46seriesa-1senior002.jpg	Edgar Link	pending
exhibit46seriesa-1senior003.jpg	Edgar Link	pending
exhibit46seriesa-1senior004.jpg	Edgar Link	pending
exhibit46seriesa-1senior005.jpg	Edgar Link	pending
exhibit46seriesa-1senior006.jpg	Edgar Link	pending
exhibit46seriesa-1senior007.jpg	Edgar Link	pending
exhibit46seriesa-1senior008.jpg	Edgar Link	pending
exhibit46seriesa-1senior009.jpg	Edgar Link	pending
exhibit46seriesa-1senior010.jpg	Edgar Link	pending
exhibit46seriesa-1senior011.jpg	Edgar Link	pending
exhibit46seriesa-1senior012.jpg	Edgar Link	pending
exhibit46seriesa-1senior013.jpg	Edgar Link	pending
exhibit46seriesa-1senior014.jpg	Edgar Link	pending
exhibit46seriesa-1senior015.jpg	Edgar Link	pending
exhibit46seriesa-1senior016.jpg	Edgar Link	pending
exhibit46seriesa-1senior017.jpg	Edgar Link	pending
exhibit46seriesa-1senior018.jpg	Edgar Link	pending
exhibit46seriesa-1senior019.jpg	Edgar Link	pending
exhibit46seriesa-1senior020.jpg	Edgar Link	pending
exhibit46seriesa-1senior021.jpg	Edgar Link	pending
exhibit46seriesa-1senior022.jpg	Edgar Link	pending
exhibit46seriesa-1senior023.jpg	Edgar Link	pending
exhibit46seriesa-1senior024.jpg	Edgar Link	pending
exhibit46seriesa-1senior025.jpg	Edgar Link	pending
exhibit46seriesa-1senior026.jpg	Edgar Link	pending
exhibit46seriesa-1senior027.jpg	Edgar Link	pending
exhibit46seriesa-1senior028.jpg	Edgar Link	pending
exhibit46seriesa-1senior029.jpg	Edgar Link	pending
exhibit46seriesa-1senior030.jpg	Edgar Link	pending
exhibit46seriesa-1senior031.jpg	Edgar Link	pending
exhibit46seriesa-1senior032.jpg	Edgar Link	pending
exhibit46seriesa-1senior033.jpg	Edgar Link	pending
exhibit46seriesa-1senior034.jpg	Edgar Link	pending
exhibit46seriesa-1senior035.jpg	Edgar Link	pending
exhibit46seriesa-1senior036.jpg	Edgar Link	pending
exhibit46seriesa-1senior037.jpg	Edgar Link	pending
exhibit46seriesa-1senior038.jpg	Edgar Link	pending
exhibit46seriesa-1senior039.jpg	Edgar Link	pending
exhibit46seriesa-1senior040.jpg	Edgar Link	pending
exhibit46seriesa-1senior041.jpg	Edgar Link	pending
exhibit46seriesa-1senior042.jpg	Edgar Link	pending
exhibit46seriesa-1senior043.jpg	Edgar Link	pending
exhibit46seriesa-1senior044.jpg	Edgar Link	pending
exhibit46seriesa-1senior045.jpg	Edgar Link	pending
exhibit46seriesa-1senior046.jpg	Edgar Link	pending
exhibit46seriesa-1senior047.jpg	Edgar Link	pending
exhibit46seriesa-1senior048.jpg	Edgar Link	pending
exhibit46seriesa-1senior049.jpg	Edgar Link	pending
exhibit46seriesa-1senior050.jpg	Edgar Link	pending
exhibit46seriesa-1senior051.jpg	Edgar Link	pending
exhibit46seriesa-1senior052.jpg	Edgar Link	pending
exhibit46seriesa-1senior053.jpg	Edgar Link	pending
exhibit46seriesa-1senior054.jpg	Edgar Link	pending
exhibit46seriesa-1senior055.jpg	Edgar Link	pending
exhibit46seriesa-1senior056.jpg	Edgar Link	pending
exhibit46seriesa-1senior057.jpg	Edgar Link	pending
exhibit46seriesa-1senior058.jpg	Edgar Link	pending
exhibit46seriesa-1senior059.jpg	Edgar Link	pending
exhibit46seriesa-1senior060.jpg	Edgar Link	pending
exhibit46seriesa-1senior061.jpg	Edgar Link	pending
exhibit47indenture.htm	Edgar Link	pending
exhibit47indenture001.jpg	Edgar Link	pending
exhibit47indenture002.jpg	Edgar Link	pending
exhibit47indenture003.jpg	Edgar Link	pending
exhibit47indenture004.jpg	Edgar Link	pending
exhibit47indenture005.jpg	Edgar Link	pending
exhibit47indenture006.jpg	Edgar Link	pending
exhibit47indenture007.jpg	Edgar Link	pending
exhibit47indenture008.jpg	Edgar Link	pending
exhibit47indenture009.jpg	Edgar Link	pending
exhibit47indenture010.jpg	Edgar Link	pending
exhibit47indenture011.jpg	Edgar Link	pending
exhibit47indenture012.jpg	Edgar Link	pending
exhibit47indenture013.jpg	Edgar Link	pending
exhibit47indenture014.jpg	Edgar Link	pending
exhibit47indenture015.jpg	Edgar Link	pending
exhibit47indenture016.jpg	Edgar Link	pending
exhibit47indenture017.jpg	Edgar Link	pending
exhibit47indenture018.jpg	Edgar Link	pending
exhibit47indenture019.jpg	Edgar Link	pending
exhibit47indenture020.jpg	Edgar Link	pending
exhibit47indenture021.jpg	Edgar Link	pending
exhibit47indenture022.jpg	Edgar Link	pending
exhibit47indenture023.jpg	Edgar Link	pending
exhibit47indenture024.jpg	Edgar Link	pending
exhibit47indenture025.jpg	Edgar Link	pending
exhibit47indenture026.jpg	Edgar Link	pending
exhibit47indenture027.jpg	Edgar Link	pending
exhibit47indenture028.jpg	Edgar Link	pending
exhibit47indenture029.jpg	Edgar Link	pending
exhibit47indenture030.jpg	Edgar Link	pending
exhibit47indenture031.jpg	Edgar Link	pending
exhibit47indenture032.jpg	Edgar Link	pending
exhibit47indenture033.jpg	Edgar Link	pending
exhibit47indenture034.jpg	Edgar Link	pending
exhibit47indenture035.jpg	Edgar Link	pending
exhibit47indenture036.jpg	Edgar Link	pending
exhibit47indenture037.jpg	Edgar Link	pending
exhibit47indenture038.jpg	Edgar Link	pending
exhibit47indenture039.jpg	Edgar Link	pending
exhibit47indenture040.jpg	Edgar Link	pending
exhibit47indenture041.jpg	Edgar Link	pending
exhibit47indenture042.jpg	Edgar Link	pending
exhibit47indenture043.jpg	Edgar Link	pending
exhibit48firstsupplement.htm	Edgar Link	pending
exhibit48firstsupplement001.jpg	Edgar Link	pending
exhibit48firstsupplement002.jpg	Edgar Link	pending
exhibit48firstsupplement003.jpg	Edgar Link	pending
exhibit48firstsupplement004.jpg	Edgar Link	pending
exhibit48firstsupplement005.jpg	Edgar Link	pending
exhibit48firstsupplement006.jpg	Edgar Link	pending
exhibit48firstsupplement007.jpg	Edgar Link	pending
exhibit48firstsupplement008.jpg	Edgar Link	pending
exhibit48firstsupplement009.jpg	Edgar Link	pending
exhibit48firstsupplement010.jpg	Edgar Link	pending
exhibit48firstsupplement011.jpg	Edgar Link	pending
exhibit48firstsupplement012.jpg	Edgar Link	pending
exhibit48firstsupplement013.jpg	Edgar Link	pending
exhibit48firstsupplement014.jpg	Edgar Link	pending
exhibit48firstsupplement015.jpg	Edgar Link	pending
exhibit49seriesb-1senior.htm	Edgar Link	pending
exhibit49seriesb-1senior001.jpg	Edgar Link	pending
exhibit49seriesb-1senior002.jpg	Edgar Link	pending
exhibit49seriesb-1senior003.jpg	Edgar Link	pending
exhibit49seriesb-1senior004.jpg	Edgar Link	pending
exhibit49seriesb-1senior005.jpg	Edgar Link	pending
exhibit49seriesb-1senior006.jpg	Edgar Link	pending
exhibit49seriesb-1senior007.jpg	Edgar Link	pending
exhibit49seriesb-1senior008.jpg	Edgar Link	pending
exhibit49seriesb-1senior009.jpg	Edgar Link	pending
exhibit49seriesb-1senior010.jpg	Edgar Link	pending
exhibit49seriesb-1senior011.jpg	Edgar Link	pending
exhibit49seriesb-1senior012.jpg	Edgar Link	pending
exhibit49seriesb-1senior013.jpg	Edgar Link	pending
exhibit49seriesb-1senior014.jpg	Edgar Link	pending
exhibit49seriesb-1senior015.jpg	Edgar Link	pending
exhibit49seriesb-1senior016.jpg	Edgar Link	pending
exhibit49seriesb-1senior017.jpg	Edgar Link	pending
exhibit49seriesb-1senior018.jpg	Edgar Link	pending
exhibit49seriesb-1senior019.jpg	Edgar Link	pending
exhibit49seriesb-1senior020.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
exhibit49seriesb-1senior021.jpg	Edgar Link	pending
exhibit49seriesb-1senior022.jpg	Edgar Link	pending
exhibit49seriesb-1senior023.jpg	Edgar Link	pending
exhibit49seriesb-1senior024.jpg	Edgar Link	pending
exhibit49seriesb-1senior025.jpg	Edgar Link	pending
exhibit49seriesb-1senior026.jpg	Edgar Link	pending
exhibit49seriesb-1senior027.jpg	Edgar Link	pending
exhibit49seriesb-1senior028.jpg	Edgar Link	pending
exhibit49seriesb-1senior029.jpg	Edgar Link	pending
exhibit49seriesb-1senior030.jpg	Edgar Link	pending
exhibit49seriesb-1senior031.jpg	Edgar Link	pending
exhibit49seriesb-1senior032.jpg	Edgar Link	pending
exhibit49seriesb-1senior033.jpg	Edgar Link	pending
exhibit49seriesb-1senior034.jpg	Edgar Link	pending
exhibit49seriesb-1senior035.jpg	Edgar Link	pending
exhibit49seriesb-1senior036.jpg	Edgar Link	pending
exhibit49seriesb-1senior037.jpg	Edgar Link	pending
exhibit49seriesb-1senior038.jpg	Edgar Link	pending
exhibit49seriesb-1senior039.jpg	Edgar Link	pending
exhibit49seriesb-1senior040.jpg	Edgar Link	pending
exhibit49seriesb-1senior041.jpg	Edgar Link	pending
exhibit49seriesb-1senior042.jpg	Edgar Link	pending
exhibit49seriesb-1senior043.jpg	Edgar Link	pending
exhibit49seriesb-1senior044.jpg	Edgar Link	pending
exhibit49seriesb-1senior045.jpg	Edgar Link	pending
exhibit49seriesb-1senior046.jpg	Edgar Link	pending
exhibit49seriesb-1senior047.jpg	Edgar Link	pending
exhibit49seriesb-1senior048.jpg	Edgar Link	pending
exhibit49seriesb-1senior049.jpg	Edgar Link	pending
exhibit49seriesb-1senior050.jpg	Edgar Link	pending
exhibit49seriesb-1senior051.jpg	Edgar Link	pending
exhibit49seriesb-1senior052.jpg	Edgar Link	pending
exhibit49seriesb-1senior053.jpg	Edgar Link	pending
exhibit49seriesb-1senior054.jpg	Edgar Link	pending
exhibit49seriesb-1senior055.jpg	Edgar Link	pending
exhibit49seriesb-1senior056.jpg	Edgar Link	pending
exhibit49seriesb-1senior057.jpg	Edgar Link	pending
exhibit49seriesb-1senior058.jpg	Edgar Link	pending
exhibit49seriesb-1senior059.jpg	Edgar Link	pending
exhibit49seriesb-1senior060.jpg	Edgar Link	pending
exhibit49seriesb-1senior061.jpg	Edgar Link	pending
exhibit97clawbackpolicyf.htm	Edgar Link	pending
exhibit97clawbackpolicyf001.jpg	Edgar Link	pending
exhibit97clawbackpolicyf002.jpg	Edgar Link	pending
exhibit97clawbackpolicyf003.jpg	Edgar Link	pending
exhibit97clawbackpolicyf004.jpg	Edgar Link	pending
fsr-20231231.htm	Edgar Link	pending
fsr-20231231.xsd	Edgar Link	pending
fsr-20231231_g1.jpg	Edgar Link	pending
fsr-20231231_g10.jpg	Edgar Link	pending
fsr-20231231_g2.jpg	Edgar Link	pending
fsr-20231231_g3.jpg	Edgar Link	pending
fsr-20231231_g4.jpg	Edgar Link	pending
fsr-20231231_g5.jpg	Edgar Link	pending
fsr-20231231_g6.jpg	Edgar Link	pending
fsr-20231231_g7.jpg	Edgar Link	pending
fsr-20231231_g8.jpg	Edgar Link	pending
fsr-20231231_g9.jpg	Edgar Link	pending
fsrex212023123110-k.htm	Edgar Link	pending
fsrex232023123110-k.htm	Edgar Link	pending
fsrex3112023123110-k.htm	Edgar Link	pending
fsrex3122023123110-k.htm	Edgar Link	pending
fsrex3212023123110-k.htm	Edgar Link	pending
fsrex3222023123110-k.htm	Edgar Link	pending
fsrex452023123110-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
fsr-20231231_def.xml	Edgar Link	unprocessable
fsr-20231231_lab.xml	Edgar Link	unprocessable
fsr-20231231_pre.xml	Edgar Link	unprocessable
fsr-20231231_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
fsr-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Fisker Inc./DE

2023 Q4 Form 10-K Financial Statement

#000172099024000045 Filed on April 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission